Wednesday, March 29, 2023
HISA Answers Frequently-Asked Questions About Anti-Doping And Medication Control Program
HISA Answers Frequently-Asked Questions About Anti-Doping And Medication Control Program: the anticipated March 27 implementation of HISA's Anti-Doping and Medication Control (ADMC) Program is approaching
U.S. Thoroughbred Racing Enters New Era As HISA’s Uniform Anti-Doping Program Takes Effect
U.S. Thoroughbred Racing Enters New Era As HISA’s Uniform Anti-Doping Program Takes Effect: New and enhanced anti-doping regulations took effect in U.S. Thoroughbred horse racing Monday following the Federal Trade Commission’s (FTC) approval of the Horseracing Integrity and Safety Authority’s (HISA) Anti-Doping and Medication Control (ADMC) Program.
Footnote in FTC order address compounded medications used in racehorses-has to be compliant with Animal Medicinal Drug Use Clarification Act (AMDUCA) and the FDA Guidance for Industry (GFI) #256
Anti-Doping and Medication Control (ADMC) Program became effective March 27, 2023.
8 Proposed Rule 4111 (“S0 Non-approved Substances”) states: “Any pharmacological substance that (i) is not addressed by Rules 4112 through 4117 [other categories of banned substances], (ii) has no current approval by any governmental regulatory health authority for veterinary or human use, and (iii) is not universally recognized by veterinary regulatory authorities as a valid veterinary use, is prohibited at all times. For the avoidance of doubt, compounded products compliant with the Animal Medicinal Drug Use Clarification Act (AMDUCA) and the FDA Guidance for Industry (GFI) #256 (also known as Compounding Animal Drugs from Bulk Drug Substances) are not prohibited under this section S0.” Notice, 88 Fed. Reg. at 5122
| April 13, 2023 | Individuals may participate via WebEx. WebEx information will be provided on meeting agenda once released. | |||
| March 23, 2023 Webcast Part 1 | Individuals may participate in person or via WebEx. In person participation: California State Board of Pharmacy Remote participation: WebEx information is provided on the meeting agenda. | 3/23/23 Agenda | 3/23/23 Additional Meeting Materials 1 3/23/23 Additional Meeting Materials 2 3/23/23 Additional Meeting Materials 3 3/23/23 Additional Meeting Materials 4 | |
| February 15, 2023 Webcast | Individuals may participate in person or via WebEx. In person participation: California State Board of Pharmacy Remote participation: WebEx information is provided on the meeting agenda. | 2/15/23 Agenda | 2/15/23 Meeting Materials Updated 2/17/23 2/15/23 Additional Meeting Materials 1 2/15/23 Additional Meeting Materials 2 2/15/23 Additional Meeting Materials 3 2/15/23 Additional Meeting Materials 4 | |
| January 23, 2023 Webcast | Individuals may participate via WebEx. WebEx information will be provided on meeting agenda once released. | 1/23/23 Agenda | 1/23/23 Meeting Materials | 1/23/23 Minute |
Subscribe to:
Posts (Atom)